Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Uterine Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Kidney Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1

Interventions

aldesleukin 9Sunitinib 5Interferon-alpha 4Chemotherapy, Adjuvant 4pembrolizumab 3Vincristine 3Neoadjuvant Therapy 3Dactinomycin 3Cyclophosphamide 3Bevacizumab 3sargramostim 2fludarabine phosphate 2Robotic Surgical Procedures 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Laparoscopy 2Gene Expression Profiling 2Fluorouracil 2Etoposide 2Electroporation 2Doxorubicin 2Carboplatin 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1toripalimab 1temsirolimus 1spartalizumab 1pazopanib 1orantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Kidney Neoplasms × Health × Clear all
NCT01447199 2020-01-07

The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)

M.D. Anderson Cancer Center

Unknown
2,000 enrolled
DermatologicGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Kidney Neoplasms, Skin Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡